47 filings
8-K
NKTX
Nkarta Inc
27 Jun 24
Patient screening underway in Ntrust-1, the first U.S.-based clinical trial of an engineered NK cell therapy for the treatment of lupus nephritis
6:45am
8-K
NKTX
Nkarta Inc
13 Jun 24
Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors
4:22pm
8-K
NKTX
Nkarta Inc
9 May 24
Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights
4:04pm
8-K
NKTX
Nkarta Inc
28 Mar 24
Other Events
4:08pm
8-K
NKTX
Nkarta Inc
25 Mar 24
Regulation FD Disclosure
6:05am
8-K
ot730bt29a 0ksh0i4
21 Mar 24
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
4:15pm
8-K
w6j 2qbp1gt7ylakesp
8 Jan 24
Regulation FD Disclosure
8:50am
8-K
e8k1o6qq1q
9 Nov 23
Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights
4:06pm
8-K
7qpj6
17 Oct 23
Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis
7:06am
8-K
vm60faf9pkw otk1
16 Oct 23
Nkarta to Host Conference Call on Tuesday, October 17 at 8am ET to Discuss Expansion of Clinical Pipeline and Organizational Cost Measures
4:07pm
8-K
i6udw7jgcc ql
10 Aug 23
Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights
7:05am
8-K
gksyts vwz3ahty
5 Jul 23
Nkarta Appoints Alyssa Levin Chief Financial and Business Officer
4:09pm
8-K
ene 7d3kxqwtf9qqv
27 Jun 23
Nkarta Updates Clinical Progress of CAR-NK Cell Therapy NKX101 for Patients with Relapsed or Refractory Acute Myeloid Leukemia
7:07am
8-K
nldv2wd 0v
26 Jun 23
Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX101 NK Cell Therapy Program
4:07pm
8-K
sysqp5l0k3 k0
9 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:09pm
8-K
z64ww6m
11 May 23
Nkarta Reports First Quarter 2023 Financial Results and Corporate Highlights
4:06pm
8-K
z48mk5i27u
30 Mar 23
Nkarta Announces Departure of Chief Financial & Business Officer
4:11pm
8-K
cnqx9r0z
16 Mar 23
Nkarta Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
4:09pm
8-K
z6iopayfh x4k
9 Jan 23
Regulation FD Disclosure
4:48pm
8-K
pdecz wlg0i1hy
5 Dec 22
Regulation FD Disclosure
7:39am